-
A650509-5mg
ACA-28 (C007B-325837)
Price: $388.92List Price: $432.14ACA-28 (compound 2a) is a potent ERK MAPK signaling modulator. ACA-28 selectively inhibits cancer cell growth by inducing apoptosis with ERK hyperactivationACA-28 inhibits cell growth of melanoma cells (SK-MEL-28) and normal melanocytes (NHEM), with -
A648781-1mg
AcLys-PABC-VC-Aur0101 (C007B-325355)
Price: $706.50List Price: $785.00AcLys-PABC-VC-Aur0101 is a agent-linker conjugate for ADC (anti-CXCR4 ADC) with potent antitumor activity by using Aur0101 (an auristatin microtubule inhibitor), linked via the cleavable linker AcLys-PABC-VCForm:SolidIC50&: Target:Auristatin. -
A648781-5mg
AcLys-PABC-VC-Aur0101 (C007B-325356)
Price: $1,399.74List Price: $1,555.27AcLys-PABC-VC-Aur0101 is a agent-linker conjugate for ADC (anti-CXCR4 ADC) with potent antitumor activity by using Aur0101 (an auristatin microtubule inhibitor), linked via the cleavable linker AcLys-PABC-VCForm:SolidIC50&: Target:Auristatin. -
A423984-1ml
Afatinib (C007B-021589)
Price: $312.66List Price: $347.40Afatinib (BIBW2992) is an irreversible EGFR/Neu inhibitor with an IC50 of 14 nM. Afatinib is a potent inhibitor of EGFR phosphorylation. Afatinib showed positive results in assays against a variety of human cancer cell lines, including A431, murine -
17988-1
Afuresertib (hydrochloride)-1 mg
Price: $131.77List Price: $146.41A selective, orally bioavailable inhibitor of Akt1, 2, and 3 (Kis = 0.08, 2, and 2.6 nM, respectively) inhibits the proliferation of human cancer cell lines with Akt pathway activation and various cell lines derived from hematologic malignancies. -
17988-25
Afuresertib (hydrochloride)-25 mg
Price: $1,349.46List Price: $1,499.40A selective, orally bioavailable inhibitor of Akt1, 2, and 3 (Kis = 0.08, 2, and 2.6 nM, respectively) inhibits the proliferation of human cancer cell lines with Akt pathway activation and various cell lines derived from hematologic malignancies. -
A646676-100mg
Afuresertib hydrochloride (C007B-324809)
Price: $687.04List Price: $763.38Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with K i s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.In VitroAfuresertib (GSK 2110183) exhibits -
A646676-10mg
Afuresertib hydrochloride (C007B-324810)
Price: $198.87List Price: $220.96Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with K i s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.In VitroAfuresertib (GSK 2110183) exhibits -
A646676-2mg
Afuresertib hydrochloride (C007B-324811)
Price: $115.79List Price: $128.65Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with K i s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.In VitroAfuresertib (GSK 2110183) exhibits -
A646676-50mg
Afuresertib hydrochloride (C007B-324812)
Price: $419.94List Price: $466.60Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with K i s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.In VitroAfuresertib (GSK 2110183) exhibits -
A646676-5mg
Afuresertib hydrochloride (C007B-324813)
Price: $146.94List Price: $163.27Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with K i s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.In VitroAfuresertib (GSK 2110183) exhibits -
A654694-1ml
Afuresertib hydrochloride (C007B-326240)
Price: $160.79List Price: $178.65Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with K i s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.In VitroAfuresertib (GSK 2110183) exhibits